Charter enrollment closes July 15 · reopens at $347/month, lock your rate now

Charter enrollment closes July 15 · reopens at $347/monthSee if you qualify →Charter enrollment closes July 15 · reopens at $347/monthSee if you qualify →

Reopens at $347 after July 15.Qualify →

Programs How it works Our team Science

FAQ About Contact

See if you qualify

Metabolic assessment

Understand what is actually driving your metabolism

An integrated metabolic and hormonal practice for women whose biology shifted — whatever year it started.

Programs

The Membership
Start Screening

Clinical

Medical Team
Science
How It Works
Journal

Weightstry

About
FAQ
Contact

Legal

Privacy Policy
Terms of Use
HIPAA Notice
Compound Disclosure
Refund Policy
Accessibility

Compound Medication Disclosure

Weightstry works with state-licensed compounding pharmacies to prepare certain GLP-1 medications, including compounded semaglutide and compounded tirzepatide. Compounded medications are not approved by the U.S. Food and Drug Administration. Before your medication is dispensed, your Weightstry provider will discuss the specific medication prescribed, its active ingredient, potential risks and side effects, and any FDA-approved alternatives available to you.

LegitScript certified·Verify

See if you qualify→